The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds

Eric P M Prinssen, Wouter Koek, Mark S. Kleven

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Many antipsychotics have marked antagonist effects at 5-hydroxytryptamine (5-HT(2C)) receptors in vitro, which, however, have been difficult to show in behavioral assays. Here, we used two assays - hypolocomotion and hypophagia induced by the 5-HT(2C) receptor agonist 1-(3-chlorophenyl)piperazine (mCPP) - to try to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics in vivo. Clozapine, olanzapine, pipamperone, and trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz-[2,3:6,7]oxepino[4,5-C] pyrrolidino maleate (ORG 5222), modestly, but significantly, attenuated mCPP (10 mg/kg)-induced hypolocomotion. In contrast, risperidone and loxapine were inactive. The putative antipsychotic ORG 5222 significantly attenuated mCPP (5 mg/kg)-induced hypophagia, whereas the other antipsychotics were inactive. Selective antagonists at dopamine D2-like receptors, α1-adrenoceptors, α2-adrenoceptors, or muscarinic receptors were not able to antagonize the effects of mCPP in either assay. The results suggest that mCPP-induced hypolocomotion can be used to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics, whereas mCPP-induced hypophagia appeared to be sensitive only to compounds highly selective for 5-HT(2C) receptors. Together, these assays may help to characterize functional, in vivo, 5-HT(2C) receptor antagonist properties of antipsychotics. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)57-67
Number of pages11
JournalEuropean Journal of Pharmacology
Volume388
Issue number1
DOIs
StatePublished - Jan 24 2000
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT2C
Antipsychotic Agents
pipamperone
olanzapine
Adrenergic Receptors
Loxapine
Risperidone
Dopamine D2 Receptors
Clozapine
Muscarinic Receptors
Serotonin

Keywords

  • 5-HT (5-hydroxytryptamine)
  • 5-HT(2C) receptor
  • Antipsychotic
  • Behavior
  • Food intake
  • Hypolocomotion
  • Hypophagia
  • Locomotor activity
  • mCPP-(3-chlorophenyl)piperazine
  • Neuroleptic
  • serotonin

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds. / Prinssen, Eric P M; Koek, Wouter; Kleven, Mark S.

In: European Journal of Pharmacology, Vol. 388, No. 1, 24.01.2000, p. 57-67.

Research output: Contribution to journalArticle

@article{7dccef24f54e4e469a20b7c40c27a40d,
title = "The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds",
abstract = "Many antipsychotics have marked antagonist effects at 5-hydroxytryptamine (5-HT(2C)) receptors in vitro, which, however, have been difficult to show in behavioral assays. Here, we used two assays - hypolocomotion and hypophagia induced by the 5-HT(2C) receptor agonist 1-(3-chlorophenyl)piperazine (mCPP) - to try to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics in vivo. Clozapine, olanzapine, pipamperone, and trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz-[2,3:6,7]oxepino[4,5-C] pyrrolidino maleate (ORG 5222), modestly, but significantly, attenuated mCPP (10 mg/kg)-induced hypolocomotion. In contrast, risperidone and loxapine were inactive. The putative antipsychotic ORG 5222 significantly attenuated mCPP (5 mg/kg)-induced hypophagia, whereas the other antipsychotics were inactive. Selective antagonists at dopamine D2-like receptors, α1-adrenoceptors, α2-adrenoceptors, or muscarinic receptors were not able to antagonize the effects of mCPP in either assay. The results suggest that mCPP-induced hypolocomotion can be used to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics, whereas mCPP-induced hypophagia appeared to be sensitive only to compounds highly selective for 5-HT(2C) receptors. Together, these assays may help to characterize functional, in vivo, 5-HT(2C) receptor antagonist properties of antipsychotics. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "5-HT (5-hydroxytryptamine), 5-HT(2C) receptor, Antipsychotic, Behavior, Food intake, Hypolocomotion, Hypophagia, Locomotor activity, mCPP-(3-chlorophenyl)piperazine, Neuroleptic, serotonin",
author = "Prinssen, {Eric P M} and Wouter Koek and Kleven, {Mark S.}",
year = "2000",
month = "1",
day = "24",
doi = "10.1016/S0014-2999(99)00859-6",
language = "English (US)",
volume = "388",
pages = "57--67",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds

AU - Prinssen, Eric P M

AU - Koek, Wouter

AU - Kleven, Mark S.

PY - 2000/1/24

Y1 - 2000/1/24

N2 - Many antipsychotics have marked antagonist effects at 5-hydroxytryptamine (5-HT(2C)) receptors in vitro, which, however, have been difficult to show in behavioral assays. Here, we used two assays - hypolocomotion and hypophagia induced by the 5-HT(2C) receptor agonist 1-(3-chlorophenyl)piperazine (mCPP) - to try to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics in vivo. Clozapine, olanzapine, pipamperone, and trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz-[2,3:6,7]oxepino[4,5-C] pyrrolidino maleate (ORG 5222), modestly, but significantly, attenuated mCPP (10 mg/kg)-induced hypolocomotion. In contrast, risperidone and loxapine were inactive. The putative antipsychotic ORG 5222 significantly attenuated mCPP (5 mg/kg)-induced hypophagia, whereas the other antipsychotics were inactive. Selective antagonists at dopamine D2-like receptors, α1-adrenoceptors, α2-adrenoceptors, or muscarinic receptors were not able to antagonize the effects of mCPP in either assay. The results suggest that mCPP-induced hypolocomotion can be used to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics, whereas mCPP-induced hypophagia appeared to be sensitive only to compounds highly selective for 5-HT(2C) receptors. Together, these assays may help to characterize functional, in vivo, 5-HT(2C) receptor antagonist properties of antipsychotics. Copyright (C) 2000 Elsevier Science B.V.

AB - Many antipsychotics have marked antagonist effects at 5-hydroxytryptamine (5-HT(2C)) receptors in vitro, which, however, have been difficult to show in behavioral assays. Here, we used two assays - hypolocomotion and hypophagia induced by the 5-HT(2C) receptor agonist 1-(3-chlorophenyl)piperazine (mCPP) - to try to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics in vivo. Clozapine, olanzapine, pipamperone, and trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz-[2,3:6,7]oxepino[4,5-C] pyrrolidino maleate (ORG 5222), modestly, but significantly, attenuated mCPP (10 mg/kg)-induced hypolocomotion. In contrast, risperidone and loxapine were inactive. The putative antipsychotic ORG 5222 significantly attenuated mCPP (5 mg/kg)-induced hypophagia, whereas the other antipsychotics were inactive. Selective antagonists at dopamine D2-like receptors, α1-adrenoceptors, α2-adrenoceptors, or muscarinic receptors were not able to antagonize the effects of mCPP in either assay. The results suggest that mCPP-induced hypolocomotion can be used to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics, whereas mCPP-induced hypophagia appeared to be sensitive only to compounds highly selective for 5-HT(2C) receptors. Together, these assays may help to characterize functional, in vivo, 5-HT(2C) receptor antagonist properties of antipsychotics. Copyright (C) 2000 Elsevier Science B.V.

KW - 5-HT (5-hydroxytryptamine)

KW - 5-HT(2C) receptor

KW - Antipsychotic

KW - Behavior

KW - Food intake

KW - Hypolocomotion

KW - Hypophagia

KW - Locomotor activity

KW - mCPP-(3-chlorophenyl)piperazine

KW - Neuroleptic

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=0033984692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033984692&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(99)00859-6

DO - 10.1016/S0014-2999(99)00859-6

M3 - Article

C2 - 10657547

AN - SCOPUS:0033984692

VL - 388

SP - 57

EP - 67

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -